Mathieu, M G

The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. [electronic resource] - Cell death & disease Feb 2014 - e1061 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2041-4889

10.1038/cddis.2014.29 doi


ATP Binding Cassette Transporter, Subfamily B
ATP Binding Cassette Transporter, Subfamily B, Member 1--metabolism
Animals
Antineoplastic Agents--pharmacology
Cell Line, Tumor
Cell Proliferation
DEAD-box RNA Helicases--genetics
Drug Resistance, Neoplasm
Gene Expression Regulation, Enzymologic
Gene Expression Regulation, Neoplastic
Humans
Interferon-alpha--pharmacology
Janus Kinase 1--metabolism
Melanoma--drug therapy
Mice
Mice, Inbred NOD
Mice, SCID
Neoplasm Proteins--genetics
Neoplastic Stem Cells--drug effects
Nuclear Proteins--genetics
Phosphorylation
Promyelocytic Leukemia Protein
RNA Interference
RNA, Messenger--metabolism
STAT Transcription Factors--metabolism
Signal Transduction--drug effects
Skin Neoplasms--drug therapy
Spheroids, Cellular
Suppressor of Cytokine Signaling 1 Protein
Suppressor of Cytokine Signaling Proteins--genetics
TYK2 Kinase--metabolism
Time Factors
Transcription Factors--genetics
Transfection
Tumor Burden
Tumor Suppressor Proteins--genetics
Ubiquitination